Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Class I drug recalls - the high-risk category

Class I is the FDA's most serious recall category: a reasonable probability that using the product will cause serious health consequences or death. It is a small share of all recalls, but the one to check first if a medication you take appears here.

1,750 recalls, newest first.

Class I · High risk

Cord Care POWDER

Microbial Contamination of a Non-Sterile Product: Product tested positive for Cronobacter Sakazakii.

Terminated Microbial contamination Wishgarden Herbs, Incorporated D-0219-2021
Class I · High risk

Happy Ducts Compress

Microbial Contamination of a Non-Sterile Product: Product tested positive for Cronobacter Sakazakii.

Terminated Microbial contamination Wishgarden Herbs, Incorporated D-0218-2021
Class I · High risk

NP Thyroid 120

Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.

Terminated Wrong potency / content Acella Pharmaceuticals, LLC NDC 42192-328-01 D-0036-2021
Class I · High risk

NP Thyroid 15

Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.

Terminated Wrong potency / content Acella Pharmaceuticals, LLC NDC 42192-327-01 D-0035-2021
Class I · High risk

Red-E Tablet

Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.

Terminated Chemical / undeclared The Protein Shoppe D-1595-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3305-4 D-1619-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3308-4 D-1618-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3303-1 D-1617-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3302-1 D-1616-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3299-6 D-1615-2020
Class I · High risk

WP Thyroid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-5550-4 D-1614-2020
Class I · High risk

Goldenseal Root Powder Organic

Microbial Contamination of Non-Sterile Products: FDA laboratory analysis found product to be contaminated with various microorganisms including Enterobacter cloacae, Cronobacter sakazakii, Cronobacter dublinensis, among others.

Terminated Microbial contamination Maison Terre, LLC D-1584-2020
Class I · High risk

Tranexamic Acid Injection

Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.

Terminated Labeling / mix-up Mylan Institutional LLC NDC 67457-197-00 D-1576-2020
Class I · High risk

Amiodarone Hydrochloride Injection

Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.

Terminated Labeling / mix-up Mylan Institutional LLC NDC 67457-153-99 D-1575-2020
Class I · High risk

Heparin Sodium 10

Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

Terminated Cross-contamination SCA Pharmaceuticals D-1553-2020
Class I · High risk

Heparin Sodium 5

Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

Terminated Cross-contamination SCA Pharmaceuticals D-1552-2020

Recalls by year